| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Vigil Neuroscience, Inc. | General Counsel | Stock Option Award (Right to Buy) | 85 K | $648 K | $7.62 | May 3, 2024 | Direct |
| Vigil Neuroscience, Inc. | General Counsel | Stock Option Grant (Right to Buy) | 116 K | Mar 1, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| VIGL | Vigil Neuroscience, Inc. | May 3, 2024 | 4 | $0 | 4 | May 7, 2024 | General Counsel |
| VIGL | Vigil Neuroscience, Inc. | Mar 1, 2024 | 1 | $0 | 4 | Mar 1, 2024 | General Counsel |
| VIGL | Vigil Neuroscience, Inc. | Mar 1, 2023 | 1 | $0 | 4 | Mar 3, 2023 | General Counsel |
| VIGL | Vigil Neuroscience, Inc. | May 3, 2022 | 1 | $15.1 K | 4 | May 4, 2022 | General Counsel |
| VIGL | Vigil Neuroscience, Inc. | Apr 19, 2022 | 1 | $0 | 4 | Apr 20, 2022 | General Counsel |
| VIGL | Vigil Neuroscience, Inc. | Apr 19, 2022 | 0 | $0 | 3 | Apr 20, 2022 | General Counsel |